Michael Chi - 31 May 2024 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Commercial Officer
Signature
/s/ Soleil Boughton, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
31 May 2024
Net transactions value
-$7,483,966
Form type
4
Filing time
04 Jun 2024, 16:19:06 UTC
Previous filing
19 Mar 2024
Next filing
12 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise $15,686 +2,300 +1.3% $6.82 178,972 31 May 2024 Direct F1, F2
transaction HIMS Class A Common Stock Sale $46,452 -2,300 -1.3% $20.20 176,672 31 May 2024 Direct F1, F3
transaction HIMS Class A Common Stock Options Exercise $1,973,344 +393,881 +223% $5.01 570,553 31 May 2024 Direct F1
transaction HIMS Class A Common Stock Sale $6,681,586 -345,423 -61% $19.34 225,130 31 May 2024 Direct F1, F4
transaction HIMS Class A Common Stock Sale $977,306 -48,458 -22% $20.17 176,672 31 May 2024 Direct F1, F5
transaction HIMS Class A Common Stock Options Exercise $695,381 +101,962 +58% $6.82 278,634 03 Jun 2024 Direct F1
transaction HIMS Class A Common Stock Sale $2,141,202 -101,962 -37% $21.00 176,672 03 Jun 2024 Direct F1
transaction HIMS Class A Common Stock Options Exercise $130,542 +19,141 +11% $6.82 195,813 03 Jun 2024 Direct F1
transaction HIMS Class A Common Stock Sale $389,575 -19,141 -9.8% $20.35 176,672 03 Jun 2024 Direct F1, F6
transaction HIMS Class A Common Stock Options Exercise $20,521 +4,096 +2.3% $5.01 180,768 03 Jun 2024 Direct F1
transaction HIMS Class A Common Stock Sale $83,318 -4,096 -2.3% $20.34 176,672 03 Jun 2024 Direct F1, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -2,300 -0.66% $0.000000 346,132 31 May 2024 Class A Common Stock 2,300 $6.82 Direct F1, F8
transaction HIMS Stock Option (right to buy) Options Exercise $0 -393,881 -47% $0.000000 436,682 31 May 2024 Class A Common Stock 393,881 $5.01 Direct F1, F9
transaction HIMS Stock Option (right to buy) Options Exercise $0 -101,962 -29% $0.000000 244,170 03 Jun 2024 Class A Common Stock 101,962 $6.82 Direct F1, F8
transaction HIMS Stock Option (right to buy) Options Exercise $0 -19,141 -7.8% $0.000000 225,029 03 Jun 2024 Class A Common Stock 19,141 $6.82 Direct F1, F8
transaction HIMS Stock Option (right to buy) Options Exercise $0 -4,096 -0.94% $0.000000 432,586 03 Jun 2024 Class A Common Stock 4,096 $5.01 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024 by the Reporting Person.
F2 Includes 967 shares acquired on May 20, 2024, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan.
F3 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.345. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.92 - $19.91. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F5 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.92 - $20.38. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.90. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F7 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.77. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F8 The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.
F9 The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.